Stocks

The table gives an overview of all stocks, alphabetically sorted.
 EAB Group EAB Mar 5, 2021 3.28 0.00   
 Eezy Oyj EEZY Mar 5, 2021 5.12 -1.16   
 Efecte PLC EFECTE Mar 5, 2021 13.00 -2.99   
 Elecster A ELEAV Mar 5, 2021 9.50 -2.06   
 Elisa ELISA Mar 5, 2021 49.65 -0.10   
 Endomines ENDOM Mar 5, 2021 0.25 0.00   
 Enedo ENEDO Mar 5, 2021 0.66 0.00   
 Enento Group ENENTO Mar 5, 2021 33.90 -0.29   
 eQ EQV1V Mar 5, 2021 17.75 0.00   
 Ericsson B ERIBR Mar 5, 2021 10.05 -1.90   
 Etteplan ETTE Mar 5, 2021 14.25 -1.04   
 Evli Pankki EVLI Mar 5, 2021 17.00 -1.45   
 Exel Composites EXL1V Mar 5, 2021 8.32 -2.80   
 F-Secure FSC1V Mar 5, 2021 3.75 +0.67   
 Faron Pharmaceuticals Oyj FARON Mar 5, 2021 3.76 +0.53   
 Fellow Finance Oyj FELLOW Mar 5, 2021 2.76 0.00   
 Finnair FIA1S Mar 5, 2021 0.69 -2.07   
 Fiskars A FSKRS Mar 5, 2021 15.12 -0.13   
 Fodelia Oyj FODELIA Mar 5, 2021 7.68 0.00   
 Fondia Oyj FONDIA Mar 5, 2021 7.18 -0.28   
 Fortum FORTUM Mar 5, 2021 20.77 -0.14   
 Glaston GLA1V Mar 5, 2021 0.82 -2.14   
 Gofore PLC GOFORE Mar 5, 2021 18.55 +1.92   
 Harvia HARVIA Mar 5, 2021 28.50 +0.35   
 HKScan A HKSAV Mar 5, 2021 2.23 +2.53   
 Honkarakenne B HONBS Mar 5, 2021 7.20 -3.23   
 Huhtamäki HUH1V Mar 5, 2021 38.66 +0.21   
 Ilkka-Yhtymä 1 ILK1S Mar 5, 2021 5.50 0.00   
 Ilkka-Yhtymä 2 ILK2S Mar 5, 2021 4.86 +1.25   
 Incap ICP1V Mar 5, 2021 23.30 -5.67   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK